MG mRNA CAR T-Cell Therapy: Phase 2b Trial Results
Breakthrough CAR T-Cell Therapy Shows Promise for Generalized Myasthenia Gravis In a landmark clinical trial, a novel CAR T-cell therapy engineered with mRNA technology has demonstrated significant efficacy in treating generalized myasthenia gravis (GMG). The findings, revealed today, offer a potential new avenue of hope for individuals battling this debilitating autoimmune disorder. A randomized, double-blind, … Read more